<DOC>
	<DOCNO>NCT02412579</DOCNO>
	<brief_summary>The purpose study determine whether genetic marker unique liver cancer present ass usefulness diagnostic tool .</brief_summary>
	<brief_title>Genetic Profiling Liver Cancer Patients Undergoing Liver Transplantation</brief_title>
	<detailed_description>Hepatocellular carcinoma ( HCC ) common form liver cancer grow trend worldwide . Decision-making regard treatment patient limited lack clinically actionable biomarkers . This pronounced case determine monitoring liver transplant recipient . In effort improve diagnosis , use circulate serum-based microRNA isoforms ( isomiRs ) serve non-invasive , screen biomarkers HCC patient pre- post-transplantation liver .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>Patients diagnosis HCC wait list liver transplantation Patients diagnosis HCC admit hospital , schedule undergo liver transplantation within follow 24 hour . Age Range : 18 75 year old Patients metastatic HCC patient diagnosis HCC wait list liver transplantation . Patients older 75 year old young 18 year old . Patients unable consent . Pregnant patient .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>HCC</keyword>
	<keyword>Liver Cancer</keyword>
</DOC>